COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 285: Articles 2841-2850  | Next

Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID
Tyrkalska, S. D., Perez-Sanz, F., Franco-Martinez, L., Peres-Rubio, C., Tvarijonaviciute, A., Martinez-Subiela, S., Mendez-Hernandez, M., Gonzalez-Aumatell, A., Carreras-Abad, C., Domenech-Marcal, E., Ceron, J. J., Cayuela, M. L., Mulero, V., Candel, S.
10.1101/2023.12.17.23300097 — Posted: 2023-12-18
Long-Term Outcomes of SARS-CoV-2 Variants and Other Respiratory Infections: Evidence from the Virus Watch Prospective Cohort in England
Beale, S., Yavlinsky, A., Fong, W. L. E., Nguyen, V., Kovar, J., Vos, T., Wulf Hansen, S., Hayward, A., Abubakar, I., Aldridge, R. W.
10.1101/2023.12.18.23300124 — Posted: 2023-12-18
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023
Carreno Quiroz, J. M., Wagner, A., Monahan, B., Floda, D., Gonzalez-Reiche, A. S., Tcheou, J., Raskin, A., Bielak, D., Singh, G., Morris, S., Fried, M., Yellin, T., Sullivan, L., Study Group, P., Sordillo, E. M., Gordon, A., van Bakel, H., Simon, V., Krammer, F.
10.1101/2023.12.18.23300131 — Posted: 2023-12-18
Beyond Borders: Spatial Disparities in the Mortality Burden of the Covid-19 pandemic across 569 European Regions (2020-2021)
Bonnet, F., Grigoriev, P., Sauerberg, M., Alliger, I., Muhlichen, M., Camarda, C.-G.
10.1101/2023.12.18.23300149 — Posted: 2023-12-18
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium
Drysdale, M., Hautekiet, T., Singh, M., Hautekiet, J., Ludikhuyze, L., Patel, V., Gibbons, D. C., De Roeck, D., Colpaert, K., Lloyd, E. J., Van Braeckel, E.
10.1101/2023.12.14.23298578 — Posted: 2023-12-18
Prevalence, risk factors and clinical presentations of post-COVID-19 condition: a follow-up study of reported COVID-19 infections in Montreal, Canada.
Allard, R., Balegamire, S. J., Malloum, K. B., Cantalino, J., Signor, C., Leclerc, P., Bergeron, G., Mercure, S.-A., Cadieux, G.
10.1101/2023.12.15.23300022 — Posted: 2023-12-17
Informing the need for a SARS-CoV-2 booster based upon the immune response among young healthy adults to variants circulating during late 2023
Nguyen, H. C., Lal, K. G., Balinsky, C. A., Smith, L., Pan, L., Cheng, Y., Fox, I., Hontz, R. D., Lizewski, S. E., Foo, H. S., Krebs, S. J., Sun, P., Letizia, A. G.
10.1101/2023.12.16.23300003 — Posted: 2023-12-17
Self-perception of mental health, COVID-19 and associated sociodemographic-contextual factors in Latin American
Roa, P., Rosas, G., Nino, G. I., Moreno, S. M., Mejia, J., Aguirre, H., Alarcon, J., Reis, R., Hino, A., Lopez, F., Salvo, D., Ramirez, A.
10.1101/2023.12.15.23300043 — Posted: 2023-12-17
Adiposity and Sex Influence on SARS-CoV-2 Antibody Response in University Students. An ESFUERSO cross-sectional study.
Perales-Torres, A. L., Perez-Navaro, L. M., Garcia-Oropesa, E. M., Diaz-Badillo, A., Martinez-Lopez, Y. E., Rosas, M., Castillo, O., Ramirez-Quintanilla, L., Cervantes, J., Sciutto, E., Munguia Cisneros, C. X., Ramirez-Pfeifer, C., Vela, L., Tapia, B., Lopez-Alvarenga, J. C.
10.1101/2023.12.15.23298521 — Posted: 2023-12-17
Retrospective analysis of Covid-19 hospitalization modelling scenarios which guided policy response in France
Langevin, M., Starck, T.
10.1101/2023.12.16.23300086 — Posted: 2023-12-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).